METTL3-mediated m6A modification facilitates Nectin-4-induced VNN1 upregulation and promotion of ESCC progression
Acta Biochimica et Biophysica Sinica · 2026
DOI: 10.3724/abbs.2025108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2026. Verfasst von Yuanfeng Long und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Tissue Engineering and Stem Cells, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Secon…. Hauptthemen laut MEDLINE: Methyltransferases, Cell Adhesion Molecules, Esophageal Neoplasms, Adenosine. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis and limited therapeutic options. N6-methyladenosine (m 6A) RNA modification plays a role in tumorigenesis, but its contributions to ESCC and the regulation of cell adhesion molecules such as Nectin-4 are not fully elucidated. In this study, we investigate the role and the regulatory mechanisms of Nectin-4 in ESCC, particularly regarding the influence of m 6A modification and its downstream metabolic effects. Our study demonstrates that methyltransferase-like protein 3 (METTL3) enhances Nectin-4 mRNA stability and expression through m 6A methylation in ESCC, as validated by actinomycin D assay, MeRIP-qPCR, and dual-luciferase reporter assay. Both METTL3 and Nectin-4 are highly expressed in ESCC tissues and promote malignant phenotypes such as proliferation, migration, and invasion. Further analysis identifies pantothenate esterase 1 (VNN1) as a downstream target of Nectin-4, mediating the oncogenic effects of the METTL3/Nectin-4 axis and promoting the biosynthesis of pantothenic acid and coenzyme A, thus driving ESCC progression. By integrating transcriptomic data, this study elucidates a key pathogenic mechanism in which the METTL3/Nectin-4/VNN1 axis regulates metabolic reprogramming to promote ESCC development. These findings provide new insights into the molecular pathology of ESCC and offer potential biomarkers and therapeutic targets for early screening, prognosis, and precision treatment for ESSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Tissue Engineering and Stem Cells, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong…
- College of Laboratory Medicine, North Sichuan Medical College, Nanchong 637000, China.
- Department of Clinical Laboratory, Chongqing High-Tech Zone BaFu Town Health Care Center, Chongqing 401329, China.
- Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong 637000, China.
Zitieren
APA
Long, Y., Yang, H., Zhang, R., Zhao, Q., Yang, M., Song, G., & Liu, K. (2026). METTL3-mediated m6A modification facilitates Nectin-4-induced VNN1 upregulation and promotion of ESCC progression. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025108
Vancouver
Long Y, Yang H, Zhang R, Zhao Q, Yang M, Song G, et al. METTL3-mediated m6A modification facilitates Nectin-4-induced VNN1 upregulation and promotion of ESCC progression. Acta Biochimica et Biophysica Sinica. 2026. doi:10.3724/abbs.2025108
BibTeX
@article{Long2026,
author = {Long, Yuanfeng and Yang, Hang and Zhang, Ruolan and Zhao, Quanneng and Yang, Mi and Song, Guiqin and Liu, Kang},
title = {METTL3-mediated m6A modification facilitates Nectin-4-induced VNN1 upregulation and promotion of ESCC progression},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2026},
doi = {10.3724/abbs.2025108}
}
EUVIMED